Needham Maintains Buy on OrthoPediatrics, Raises Price Target to $35
OrthoPediatrics Corp.
OrthoPediatrics Corp. KIDS | 0.00 |
Needham analyst Mike Matson maintains OrthoPediatrics (NASDAQ:
KIDS) with a Buy and raises the price target from $30 to $35.
